Collegium Pharmaceutical, Inc. Operating Lease Cost
Collegium Pharmaceutical, Inc. (COLL) reported Operating Lease Cost of $1.45 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-26
- Collegium Pharmaceutical, Inc. operating lease, cost for the quarter ending 2019-12-31 was $289.00K.
- Collegium Pharmaceutical, Inc. operating lease, cost for the quarter ending 2019-09-30 was $452.00K.
- Collegium Pharmaceutical, Inc. operating lease, cost for the quarter ending 2019-06-30 was $353.00K.
- Collegium Pharmaceutical, Inc. operating lease, cost for the quarter ending 2019-03-31 was $352.00K.
- Collegium Pharmaceutical, Inc. operating lease, cost for fiscal 2025 was $1.45M, a 0.21% increase from fiscal 2024.
- Collegium Pharmaceutical, Inc. operating lease, cost for fiscal 2024 was $1.44M, a 10.57% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. operating lease, cost for fiscal 2023 was $1.31M, a 27.65% decline from fiscal 2022.
- Collegium Pharmaceutical, Inc. operating lease, cost for fiscal 2022 was $1.80M, a 38.31% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.45M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $1.44M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $1.31M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $1.80M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $1.30M 10-K · filed 2024-02-22 | |||
| 2020-12-31 | $1.30M 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $741.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.09M derived: sum of 3 quarters · filed 2022-02-24 | $1.45M 10-K · filed 2022-02-24 |
| 2019-09-30 | $452.00K 10-Q · filed 2019-11-06 | $805.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.16M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $353.00K 10-Q · filed 2019-08-07 | $705.00K 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $352.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |